The program features expert presentations from regulatory scientists across multiple FDA offices, industry leaders from both innovator and generic companies, device manufacturers, and academic researchers, complemented by interactive Q&A panels and small working group discussions for in-person attendees at the end of each day
Burger LaF, M EU investigates Ozempic, weight-loss drug Saxenda after suicidal thoughts reported 2023 [Available from: Cohen D
Introduction GLP-1s, also known as GLP-1 agonists, are medications that help lower blood sugar levels and promote weight loss
Management of endocrine disease: bone complications of bariatric surgery: updates on sleeve gastrectomy, fractures, and interventions
If you're of reproductive age and considering GLP-1 treatment, understanding the evidence around pregnancy planning is crucial
Around one-quarter of that is the baby's weight